The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Systemic inflammation markers ratio in heavily pretreated NSCLC patients treated with nivolumab.
 
Lela Bitar
Speakers' Bureau - Amgen; Merck Sharp & Dohme; Roche Pharma AG; Takeda
 
Fran Seiwerth
Speakers' Bureau - Merck Sharp & Dohme; Roche
 
Lidija Ljubicic
No Relationships to Disclose
 
Drazena Srdic
Speakers' Bureau - AstraZeneca; Roche
 
Ana Bacelic-Gabelica
Speakers' Bureau - Roche; Takeda
 
Olivera Maletic
Speakers' Bureau - AstraZeneca; Bristol-Myers Squibb
 
Filip Popović
Speakers' Bureau - AstraZeneca
 
Fedza Dzubur
No Relationships to Disclose
 
Marta Korsic
Speakers' Bureau - Amgen; AstraZeneca; Merck Sharp & Dohme; Roche
 
Sonja Badovinac
Speakers' Bureau - AstraZeneca; Merck Sharp & Dohme; Roche
 
Suzana Kukulj
Speakers' Bureau - Roche
 
Sanja Plestina
Speakers' Bureau - AstraZeneca; Merck Sharp & Dohme; Pfizer; Roche
 
Miroslav Samarzija
Consulting or Advisory Role - AstraZeneca; Roche
Speakers' Bureau - Amgen; AstraZeneca; Bristol-Myers Squibb; Pfizer; Roche; Takeda
 
MARKO JAKOPOVIC
Consulting or Advisory Role - AstraZeneca; Merck Sharp & Dohme; Roche
Speakers' Bureau - Amgen; AstraZeneca; Bristol-Myers Squibb; Merck Sharp & Dohme; Roche; Takeda